- AU$47.54m
- AU$53.24m
- AU$83.62m
- 55
- 66
- 30
- 51
Annual balance sheet for SomnoMed, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 7.7 | 30.2 | 21.1 | 15.6 | 12 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 10.6 | 6.13 | 8.22 | 9.2 | 9.03 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 20.2 | 40.2 | 34.1 | 30.3 | 27.5 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 3.25 | 10.2 | 10.3 | 9.12 | 12.7 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 34.8 | 61.7 | 56.2 | 58.1 | 62.5 |
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 16 | 18.8 | 16.2 | 23.8 | 18.4 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 16.9 | 27.9 | 24 | 30.3 | 40.1 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 17.8 | 33.8 | 32.2 | 27.8 | 22.4 |
| Total Liabilities & Shareholders' Equity | 34.8 | 61.7 | 56.2 | 58.1 | 62.5 |
| Total Common Shares Outstanding |